Â鶹AV

Introduction

The Â鶹AV Biotechnology Group welcomes you to this exciting one-day symposium, a follow-up to meetings of the same title run in 2017 and 2023. This third meeting in the series will highlight recent achievements, future challenges and current trends in the use of biotransformations and biocatalysis in the industrial biotechnology sector, with an increased focus on achieving sustainability. The meeting will explore aspects of the discovery, modification and industrial application of novel enzymes for biocatalysis, as well as analytical and process engineering, synthetic biology, computational biology, biochemistry, microbiology, and chemistry, that are being harnessed to deliver new biocatalysts for the sustainable synthesis of chemical products and materials.

Deadlines

• Nov 16 2025
  Poster abstract deadline

  
• Nov 16 2025
  Early bird registration deadline

  
• Dec 15 2025
  Standard registration deadline

  

Speakers

• Amanda Jarvis Edinburgh University, United Kingdom
• Prof Tom Ward University of Basel
  , Switzerland
• Dr. Martina Letizia Contente University of Milan, Italy
• Prof Kylie Vincent Oxford University, United Kingdom
• Christophe Jaeger Astra Zeneca, Sweden
• Jason Micklefield Imperial College London, United Kingdom
• More speakers to be confirmed United Kingdom

---

Venue

The Â鶹AV

Library and Council rooms, The Â鶹AV, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom

Useful links

Committee

• Paul Dalby University College London, United Kingdom
• Sarah Cleary HydRegen Ltd, United Kingdom
• Paul Race Newcastle University, United Kingdom
• Asma Ahmed University of Nottingham, United Kingdom

---

Organised by

Prof Paul A. Dalby (University College London: p.dalby@ucl.ac.uk), Prof Paul Race (University of Bristol), Dr Sarah Cleary (HydRegen), Prof Asma Ahmed (University of Nottingham) under the auspices of the Â鶹AV Biotechnology Interest Group.

The Biotechnology Group is the focal point within the Â鶹AV for members who have an academic or industrial interest in the chemical aspects of biotechnology.The Group has annually run conferences or symposia on a diverse range of topics, including Biotransformations, Natural Products, Stem Cell Therapies, Neurological Disorders, Proteomics, and Glycomics. 

Contact information

Paul Dalby
Contact us by email

---